Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
10 min read
Focal nodular hyperplasia Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
7 August 2026
2026 Focal nodular hyperplasia strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Hepatic adenoma Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
7 August 2026
Explore the 2026 Hepatic adenoma indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
IgG4-related sclerosing cholangitis Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
7 August 2026
2026 IgG4-related sclerosing cholangitis strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.
Latest Hotspot
10 min read
Acute cholangitis Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
7 August 2026
Explore the 2026 Acute cholangitis indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Choledocholithiasis Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
7 August 2026
Explore the 2026 Choledocholithiasis indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Gallstone disease Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
7 August 2026
Explore the 2026 Gallstone disease indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Primary bile acid malabsorption Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
7 August 2026
2026 Primary bile acid malabsorption strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.
Latest Hotspot
10 min read
Biliary dyskinesia Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
7 August 2026
Explore the 2026 Biliary dyskinesia indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Autoimmune pancreatitis type 2 Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
7 August 2026
2026 Autoimmune pancreatitis type 2 strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.
Latest Hotspot
10 min read
Sphincter of Oddi dysfunction Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
7 August 2026
2026 Sphincter of Oddi dysfunction strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.
Latest Hotspot
10 min read
Groove pancreatitis Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
7 August 2026
Explore the 2026 Groove pancreatitis indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Exocrine pancreatic insufficiency Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
7 August 2026
2026 Exocrine pancreatic insufficiency strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.